Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2011
10/27/2011US20110265209 Soybean Cultivar S090249
10/27/2011US20110265208 Soybean cultivar s090245
10/27/2011US20110265207 Soybean Cultivar 95062025
10/27/2011US20110265206 Soybean cultivar s090246
10/27/2011US20110265205 Soybean Cultivar S090248
10/27/2011US20110265204 Soybean cultivar 93022415
10/27/2011US20110265203 Soybean cultivar 94222415
10/27/2011US20110265202 Engineering of plants to exhibit self-compatibility
10/27/2011US20110265201 White-stem trait containing plants
10/27/2011US20110265200 Lettuce varieties and method of production
10/27/2011US20110265199 Nucleotide sequences and polypeptides encoded thereby useful for increasing tolerance to oxidative stress in plants
10/27/2011US20110265198 Genome editing of a Rosa locus using nucleases
10/27/2011US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
10/27/2011US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011US20110265194 Them5-modified models of non-alcoholic fatty liver disease
10/27/2011US20110265192 Nuclear receptor sensor system in transgenic animal
10/27/2011US20110263835 Recombinant nell protein production
10/27/2011US20110263698 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
10/27/2011US20110263693 Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
10/27/2011US20110263689 AKT Ligands and Polynucleotides Encoding AKT Ligands
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263686 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263682 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
10/27/2011US20110263680 Reduced size self-delivering rnai compounds
10/27/2011US20110263675 Methods of modulating mesenchymal stem cell differentiation
10/27/2011US20110263673 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives
10/27/2011US20110263672 Metabolites of Wortmannin Analogs and Methods of Using the Same
10/27/2011US20110263664 Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
10/27/2011US20110263630 Synthesis of metabolically stable agents for alcohol and drug abuse
10/27/2011US20110263585 Screening Assay for Insecticides
10/27/2011US20110263581 Fused tricyclic compounds as serine-threonine protein kinase and parp modulators
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263544 1-Phenylpyrrole Derivatives
10/27/2011US20110263525 Drug composition cytotoxic for pancreatic cancer cells
10/27/2011US20110263514 Delivery of agents using interfering nanoparticles
10/27/2011US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011US20110263488 Family of pesticidal proteins and methods for their use
10/27/2011US20110263485 Bifunctional Griffithsin Analogs
10/27/2011US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011US20110263436 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
10/27/2011US20110263047 Peptide tag and uses thereof
10/27/2011US20110263028 Meganuclease recombination system
10/27/2011US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011US20110263026 Construction of Protein-Responsive shRNA/RNAi Control System Using RNP Motif
10/27/2011US20110263025 Biodegradable polydisulfide amines for gene delivery
10/27/2011US20110263023 Genes for modulating coffee maturation and methods for their use
10/27/2011US20110263022 Irradiated membrane for cell expansion
10/27/2011US20110263021 Method and device for industrial biolayer cultivation
10/27/2011US20110263020 Membrane for cell expansion
10/27/2011US20110263019 Method of Reseeding Adherent Cells Grown in a Hollow Fiber Bioreactor System
10/27/2011US20110263018 Core-shell structured delivery system for growth factors, a preparation method thereof, and use thereof for the differentiation or proliferation of cells
10/27/2011US20110263017 Technique for regulating regenration of tissue or faulty or abnormal part in organ using nell-1
10/27/2011US20110263016 Expansion of Embryonic Stem Cells
10/27/2011US20110263015 Compositions and methods for generation of pluripotent stem cells
10/27/2011US20110263014 Cleavage of Nanog by Caspases Mediates the Differentiation of Embryonic Stem Cells
10/27/2011US20110263013 Compositions And Methods For Growing Embryonic Stem Cells
10/27/2011US20110263001 Compositions and Methods for Engineering Cells
10/27/2011US20110262999 Compositions and Methods Comprising Protease Variants
10/27/2011US20110262974 Novel enzymes for use in enzymatic bleaching of food products
10/27/2011US20110262973 Methods and Compositions for DNA Manipulation
10/27/2011US20110262972 Chondroitin Synthase, Method for Producing the Same and Method for Producing Saccharide Chain-Extended Chondroitin
10/27/2011US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011US20110262967 Use of hsa-producing cells
10/27/2011US20110262965 Cell culture medium comprising small peptides
10/27/2011US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011US20110262937 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/27/2011US20110262910 Marker for colon cancer and method for detecting colon cancer
10/27/2011US20110262902 Cis-acting diversification activator and method for selective diversification of nucleic acids
10/27/2011US20110262619 Polypeptide having phytase activity and increased temperature resistance of the enzyme activity, and nucleotide sequence coding said polypeptide
10/27/2011US20110262591 Lipases with high specificity towards short chain fatty acids and uses thereof
10/27/2011US20110262564 Treatment of Cancer with Selenium Nanoparticles
10/27/2011US20110262529 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/27/2011US20110262527 Cationic lipids and methods of use
10/27/2011US20110262516 Autologous cells on a support matrix for tissue repair
10/27/2011US20110262487 De Novo Anembryonic Trophoblast Vesicles and Methods of Making and Using Them
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262482 Anti-viral compounds
10/27/2011US20110262474 Chimeric HIV Antigens
10/27/2011US20110262471 Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/27/2011US20110262469 Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax
10/27/2011US20110262467 Novel Artificial Antigen Presenting Cells and Uses Therefor
10/27/2011US20110262465 Prostate stem cells and uses thereof
10/27/2011US20110262461 Biological materials and uses thereof
10/27/2011US20110262459 Neamine Compositions and Methods of Use Thereof
10/27/2011US20110262457 Modulation of the immune response
10/27/2011US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011US20110262452 Anti-hepsin antibodies and methods using same
10/27/2011US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
10/27/2011US20110262441 Method for selective control of helper t cell function
10/27/2011US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens
10/27/2011US20110262429 Human timp-1 antibodies
10/27/2011US20110262415 Erythrocyte-based delivery system, method of preparation and uses thereof
10/27/2011US20110262414 High affinity ny-eso t cell receptors
10/27/2011US20110262408 Furin-knockdown and gm-csf-augmented (fang) cancer vaccine
10/27/2011US20110262406 Compositions and methods for targeted inactivation of hiv cell surface receptors
10/27/2011US20110262404 Novel Mesenchymal Stem Cells and Bone-Forming Cells
10/27/2011US20110262402 Therapeutic and prophylactic agents for arthritis
10/27/2011US20110262393 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
10/27/2011US20110262392 Medium derived from stem cells as a pharmaceutical composition
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 1827